Karen Peachey

Karen Peachey PhD has a diverse work experience in the healthcare industry. Karen currently serves as the Director Strategic Accounts at Cohere Health, where they focus on the retention and growth of the company's largest strategic clients. Prior to this, they worked as the Sr Director National Strategic Accounts, Health at DataLink Software, where they managed multimillion-dollar contracts for strategic payer accounts.

Karen also has experience in population health management as the Population Health Product Manager at Greenway Health. In addition, they have held advisory and consulting roles, serving as a Board Advisor/Consultant at R3intell.

Earlier in their career, Karen worked at IBM as an IBM Watson Healthcare Executive Transformation Sales, spearheading market development for healthcare and life sciences across Asia-Pacific countries. Karen has also worked in international market development at BT Global Health International Market Development, BT Global Services, where they were involved in market sizing, entry strategies, and sales cycle support for various health solutions.

Karen's experience also includes serving on the PBAC Pharmaceutical Benefits Advisory Committee, where they conducted clinical and economic evaluations of drug submissions for the Australian prescription drug market. Additionally, they were involved in international business development at The Pharmacy Guild of Australia, focusing on a software project aimed at preventing the diversion of pseudoephedrine-based products for illicit drug manufacturing.

Overall, Karen Peachey PhD has an extensive background in strategic accounts, healthcare sales, population health, market development, and advisory roles, showcasing their expertise in driving customer retention, revenue growth, and relationship growth in the healthcare industry.

Karen Peachey PhD completed their Graduate Certificate of Health Informatics at Griffith University in 2015. Prior to that, they obtained their PhD in Medicine from The University of Queensland in 2004, specializing in Clinical Risk Management & Pharmacoepidaemiology of the Elderly.